Regulation And Legal
Prism Medico Reports Zero Investor Complaints Q2 2026
Prism Medico and Pharmacy Limited files mandatory SEBI Regulation 13(3) investor complaint disclosure for quarter ended June 30, 2026.
Company reported zero investor complaints pending, received, reso
